LIF
Leukemia inhibitory factor
Also known as: CDF, DIA, HILDA, LIF_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15018
- Gene
- LIF
- Ensembl
- ENSG00000128342
- Chromosome
- 22
- Canonical length
- 202 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Cytosol
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
Canonical amino-acid sequenceUniProt
202 residues, UniProt reviewed canonical sequence.
>P15018|LIF
1 MKVLAAGVVP LLLVLHWKHG AGSPLPITPV NATCAIRHPC HNNLMNQIRS QLAQLNGSAN
61 ALFILYYTAQ GEPFPNNLDK LCGPNVTDFP PFHANGTEKA KLVELYRIVV YLGTSLGNIT
121 RDQKILNPSA LSLHSKLNAT ADILRGLLSN VLCRLCSKYH VGHVDVTYGP DTSGKDVFQK
181 KKLGCQLLGK YKQIIAVLAQ AFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LIF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 85 nTPM
- gallbladder: 45 nTPM
- adipose tissue: 35 nTPM
- lung: 32 nTPM
- appendix: 21 nTPM
- heart muscle: 18 nTPM
Single-cell type
- endometrial secretory cells: 370 nCPM
- endometrial luminal cells: 287 nCPM
- breast secretory cells: 189 nCPM
- endometrial glandular cells: 136 nCPM
- epididymal basal cells: 121 nCPM
- mast cells: 116 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 11 nTPM
- thalamus: 4.4 nTPM
- cerebral cortex: 2.4 nTPM
- medulla oblongata: 1.5 nTPM
- midbrain: 1.5 nTPM
- spinal cord: 1.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0.52
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel remodeling
- cell morphogenesis
- cell surface receptor signaling pathway via STAT
- decidualization
- embryo implantation
- fibroblast proliferation
- gene expression
- immune response
- leukemia inhibitory factor signaling pathway
- lung alveolus development
- lung lobe morphogenesis
- lung vasculature development
- macrophage differentiation
- meiotic nuclear division
- muscle organ morphogenesis
- negative regulation of cell population proliferation
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of hormone secretion
- negative regulation of meiotic nuclear division
- neuron development
- positive regulation of astrocyte differentiation
- positive regulation of cell adhesion mediated by integrin
- positive regulation of cell population proliferation
- positive regulation of fibroblast proliferation
- positive regulation of gene expression
- positive regulation of macrophage differentiation
- positive regulation of MAPK cascade
- positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis
- positive regulation of peptidyl-serine phosphorylation
- positive regulation of peptidyl-tyrosine phosphorylation
- positive regulation of receptor signaling pathway via STAT
- positive regulation of transcription by RNA polymerase II
- regulation of cell differentiation
- regulation of metanephric nephron tubule epithelial cell differentiation
- response to hypoxia
- somatic stem cell population maintenance
- stem cell differentiation
- trophoblast giant cell differentiation
Molecular functions
- cytokine activity
- growth factor activity
- leukemia inhibitory factor receptor binding
- signaling receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LIF as an antibody target. Whether an autoantibody or antibody against LIF could matter depends on whether native LIF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LIF is annotated as secreted, so native LIF circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label LIF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...